Composition options for tissue-engineered bone

Tissue Engineering

Volumn 8, Issue 4, 2002, Pages 529-539

  Orban, Janine M ^a   Marra, Kacey G ^a,b   Hollinger, Jeffrey O ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA1; ENDOTHELIAL CELL GROWTH FACTOR; LYMPHOKINE; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

AGE; ANIMAL CELL; BIOMIMETICS; BONE TISSUE; CELL STRUCTURE; CHEMICAL MODIFICATION; COMPOSITE MATERIAL; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; GENDER; HABIT; HEALTH STATUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SPATIAL SUMMATION; SYSTEMIC CIRCULATION; TISSUE ENGINEERING; VASCULARIZATION; BONE MARROW CELL; BONE MATRIX; BONE PROSTHESIS; CHEMISTRY; FORECASTING; METABOLISM; METHODOLOGY; OSTEOBLAST; PERIOSTEUM; PHYSIOLOGY;

BONE MARROW CELLS; BONE MATRIX; BONE SUBSTITUTES; ENDOTHELIAL GROWTH FACTORS; FORECASTING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; OSTEOBLASTS; PERIOSTEUM; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035988697     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/107632702760240454     Document Type: Review

References (127)

1. Prevalence and clinical features of hepatitis G virus infection in bone marrow allograft recipients
2. Transmission of human T-cell lymphotrophic virus type 1 by a deep-frozen bone allograft
3. Simian immunodeficiency virus (human HIV-II) transmission in allograft bone procedures
4. Retroviral transmission by the transplantation of connective-tissue allografts. An experimental study
5. Current status of allografting for bone tumors
6. Consolidation of massive bone allografts in limb-preserving operations for bone tumors
7. Replacement of the distal femur and proximal tibia with frozen allografts
8. Biodegradable bone repair materials. Synthetic polymers and ceramics
9. Bone regeneration materials for the mandibular and craniofacial complex
10. Poly(DL-lactic-co-glycolic acid) sponge hybridized with collagen microsponges and deposited apatite particulates
11. Bone regenerating options for the craniofacial skeleton
12. Fabrication of biodegradable polymer scaffolds to engineer trabecular bone
13. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture
14. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam
15. Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration
16. Novel three-dimensional biodegradable scaffolds for bone tissue engineering
17. Biological surface engineering: A simple system for cell pattern formation
18. Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro
19. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology
20. In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants
21. Formulation of calcium phosphates/poly(D, L-lactide) blends containing gentamicin for bone implantation
22. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices
23. Biodegradable polymeric microcellular foams by modified thermally induced phase separation method
24. Macroporous polymer foams by hydrocarbon templating
25. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method
26. Fabrication and characterization of controlled release poly(D, L-lactide-co-glycolide) millirods
27. Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts
28. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering
29. Effect of surface roughness and composition on costochondral chondrocytes is dependent on cell maturation state
30. Biosynthetic bone grafting
31. Bone-derived growth factor release from poly(alpha-hydroxy acid) implants in vitro
32. Controlled release of TGF-β1 from a biodegradable matrix for bone regeneration
33. 1-integrins
34. Rho family GTPases regulate VEGF-stimulated endothelial cell motility
35. A generalized transport model for biased cell migration in an anisotropic environment
36. A fibrin or collagen gel assay for tissue cell chemotaxis: Assessment of fibroblast chemotaxis to GRGDSP
37. Deconstructing (and reconstructing) cell migration
38. Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells
39. A tumor derived motility factor that stimulates cell migration on extracellular matrix
40. 1 integrins
41. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin
42. Establishing an immortalized human osteoprecursor cell line
43. A tissue engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats
44. Systems for therapeutic angiogenesis in tissue engineering
45. Morphogenesis of the first blood vessels
46. Angiogenesis
47. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
48. The role of fibroblast growth factors in tumour progression and angiogenesis
49. Signaling vascular morphogenesis and maintenance
50. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
51. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
52. Vascular endothelial growth factor is a secreted angiogenic mitogen
53. Ultrasound-enhanced polymer degradation and release of incorporated substances
54. A dual receptor system is required for basic fibroblast growth factor activity
55. The biology of vascular endothelial growth factor
56. Vascular endothelial growth factor and microvascular permeability
57. Mechanisms of angiogenesis and arteriogenesis
58. Vascular endothelial growth factor (VEGF) and its receptors
59. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry
60. Clinical evidence of angiogenesis after arterial gene transfer of ph VEGF 165 in patient with ischaemic limb
61. Vascular-specific growth factors and blood vessel formation
62. Vascular endothelial growth factor is a secreted angiogenic mitogen
63. Vascular endothelial growth factor (VEGF) and its receptors
64. In vivo evidence that vascular endothelial growth factor stimulates collateral formation by inducing arterial cell proliferation in a rabbit ischemic hindlimb
65. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments collateral vessel formation in a rabbit ischemic hindlimb model
66. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia
67. Gene transfer of naked DNA encoding for 3 isoforms of vascular endothelial growth factor stimulates collateral circulation development in vivo
68. Microangiographic assessment of collateral vessel formation following direct gene transfer of vascular endothelial growth factor in rats
69. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb following administration of vascular endothelial growth factor
70. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
71. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels
72. Guided migration as a novel mechanism of capillary network remodeling is regulated by basic fibroblast growth factor
73. The heparin-binding (fibroblast) growth factor family of proteins
74. Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase
75. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-dependent effect of basic fibroblast growth factor
76. The FGF family of growth factors and oncogenes
77. The role of angiogenic cytokines in cardiovascular disease
78. Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin
79. Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor
80. Effects of acidic and basic fibroblast growth factors on osteoblastic cells
81. Fibroblast growth factor and platelet derived growth factor
82. Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats
83. Stimulation of angiogenesis by FGF-1 delivered through a modified fibrin scaffold
84. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation
85. Basic fibroblast growth factor enhances bone-graft incorporation: Dose and time dependence in rats
86. Basic fibroblast growth factor infused at different times during bone graft incorporation. Titanium chamber study in rats
87. Basic fibroblast growth factor promotes bone ingrowth in porous hydroxyapatite
88. Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants
89. Fibroblast growth factor: Review
90. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits
91. Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats
92. Enhancement of angiogenesis by bFGF in mandibular bone graft healing in the rabbit
93. Potential role of fibroblast growth factor in enhancement of fracture healing
94. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats
95. The stability of recombinant human growth hormone in poly(lactic-co-glycolic) (PLGA) microspheres
96. Preparation and characterization of Japanese encephalitis virus vaccine loaded poly(L-lactide-co-glycolide) microspheres for oral immunization
97. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D, L-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique
98. Controlled release of transforming growth factor beta-1 from biodegradable polymer microparticles
99. Effects of transforming growth factor beta-1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates
100. Controlled release of fibroblast growth factor: Activity in cell culture
101. Stability and freeze-drying of cyclosporine loaded poly(D, L-lactide-glycolide) carriers
102. Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin
103. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes
104. Stabilizing insulin-like growth factor-I in poly(D, L-lactide-co-glycolide) microspheres
105. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer
106. Controlled release from coated polymer microparticles embedded in tissue-engineered scaffolds
107. Effect of a poly(propylene fumarate) foaming cement on the healing of bone defects
108. Effect of electrical stimulation on mandibular distraction osteogenesis
109. Synthesis and characterization of polypyrrole-hyaluronic acid composite biomaterials for tissue engineering applications
110. An osteoconductive collagen/hyaluronate matrix for bone regeneration
111. Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge
112. Hydroxyapatite-collagen-hyaluronic acid composite
113. Cell growth on immobilized growth factor. 7. Protein-free cell culture by using growth factor-immobilized polymer membrane
114. Enhancement of cell growth on immobilized cell-growth factor. I. Acceleration of the growth of fibroblast cells on insulin-immobilized polymer matrix in culture medium without serum
115. Cell growth on immobilized growth factor. 5. Interaction of immobilized transferring with fibroblast cells
116. Immobilized IL-2 preserves the viability of an IL-2-dependent cell line
117. Enhancement of the mitogenic effect by artificial juxtacrine stimulation using immobilized EGF
118. Mitogenic activity of water-soluble and water-insoluble insulin conjugates
119. Development of technologies aiding large-tissue engineering
120. Gradient micropattern immobilization of EGF to investigate the effect of artificial juxtacrine stimulation
121. Tumor cell haptotaxis on covalently immobilized linear and exponential gradients of a cell adhesion peptide
122. Surface micropatterning to regulate cell functions
123. Micropatterned surfaces for control of cell shape, position, and function
124. Cytoscribing: A method for micropositioning cells and the construction of two- and three-dimensional synthetic tissues
125. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels
126. In vitro organogenesis of liver tissue